Warning: The NCBI web site requires JavaScript to function. more...
APOBEC3G levels predict rates of progression to AIDS.
Jin X, Wu H, Smith H.
Retrovirology. 2007 Mar 20;4:20.
Related citations
APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.
Jin X, Brooks A, Chen H, Bennett R, Reichman R, Smith H.
J Virol. 2005 Sep;79(17):11513-6.
APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
Cho SJ, Drechsler H, Burke RC, Arens MQ, Powderly W, Davidson NO.
J Virol. 2006 Feb;80(4):2069-72.
[Study on the difference of the APOBEC3G mRNA levels among HIV long-term nonprogressors, slow progressors, people at high risks and normal people].
Liu YJ, Li L, Bao ZY, Liu SY, Zhuang DM, Li HP, Li JY.
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Apr;29(4):356-9. Chinese.
The associations of hA3G and hA3B mRNA levels with HIV disease progression among HIV-infected individuals of China.
Zhao M, Geng W, Jiang Y, Han X, Cui H, Dai D, Bao M, Pan Y, Wang Y, Zhang X, Zhang M, Qi G, Shang H.
J Acquir Immune Defic Syndr. 2010 Feb;53 Suppl 1:S4-9.
The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK, Sarr AD, Hamel D, Sankale JL, Mboup S, Kanki PJ.
AIDS Res Hum Retroviruses. 2008 Oct;24(10):1285-90.
APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression.
Vázquez-Pérez JA, Ormsby CE, Hernández-Juan R, Torres KJ, Reyes-Terán G.
Retrovirology. 2009 Mar 2;6:23.
Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.
Ulenga NK, Sarr AD, Thakore-Meloni S, Sankalé JL, Eisen G, Kanki PJ.
J Infect Dis. 2008 Aug 15;198(4):486-92.
Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
Chen K, Huang J, Zhang C, Huang S, Nunnari G, Wang FX, Tong X, Gao L, Nikisher K, Zhang H.
J Virol. 2006 Aug;80(15):7645-57.
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN, Holmes RK, Malim MH.
J Virol. 2006 Sep;80(17):8450-8.
APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
Reddy K, Winkler CA, Werner L, Mlisana K, Abdool Karim SS, Ndung'u T; CAPRISA Acute Infection Study Team.
AIDS. 2010 Jan 16;24(2):195-204.
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM.
J Exp Med. 2006 Jan 23;203(1):41-6. Epub 2006 Jan 17. Erratum in: J Exp Med. 2006 Dec 25;203(13):2963.
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
Miller JH, Presnyak V, Smith HC.
Retrovirology. 2007 Nov 24;4:81.
Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
Amoêdo ND, Afonso AO, Cunha SM, Oliveira RH, Machado ES, Soares MA.
PLoS One. 2011;6(8):e24118. Epub 2011 Aug 29.
APOBEC3G genetic variants and their influence on the progression to AIDS.
An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, Winkler CA.
J Virol. 2004 Oct;78(20):11070-6.
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
Kim S, Hughes MD, Hammer SM, Jackson JB, DeGruttola V, Katzenstein DA.
AIDS Res Hum Retroviruses. 2000 May 1;16(7):645-53.
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
Carotenuto P, Looij D, Keldermans L, de Wolf F, Goudsmit J.
AIDS. 1998 Sep 10;12(13):1591-600.
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA.
AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28.
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
Holmes RK, Koning FA, Bishop KN, Malim MH.
J Biol Chem. 2007 Jan 26;282(4):2587-95. Epub 2006 Nov 22.
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Stopak K, de Noronha C, Yonemoto W, Greene WC.
Mol Cell. 2003 Sep;12(3):591-601.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on